Independent prescriber course set up with funding for community pharmacists in Scotland

Independent prescriber course set up with funding for community pharmacists in Scotland

May 22 2018 A “bespoke, fully funded independent prescribing course for community...

New website launched to support people with atopic dermatitis

New website launched to support people with atopic dermatitis

May 22 2018 ‘Scratch Beneath the Surface’, a new UK public health initiative intended...

RPS Board election results announced with concerns raised over behaviour of some participants

RPS Board election results announced with concerns raised over behaviour of some participants

May 21 2018 The Royal Pharmaceutical Society has announced the candidates who have been elected...

NAPC issues guidance on community pharmacy role within primary care home programme

NAPC issues guidance on community pharmacy role within primary care home programme

May 18 2018 New guidance to support the integration of community pharmacy services into primary...

Survey looks to improve ways pharmacy can share information

Survey looks to improve ways pharmacy can share information

May 17 2018 The Professional Record Standards Body (PRSB) is inviting views on information...

  • Independent prescriber course set up with funding for community pharmacists in Scotland

    Independent prescriber course set up with funding for community pharmacists in Scotland

    Tuesday, 22 May 2018 13:06
  • New website launched to support people with atopic dermatitis

    New website launched to support people with atopic dermatitis

    Tuesday, 22 May 2018 13:02
  • RPS Board election results announced with concerns raised over behaviour of some participants

    RPS Board election results announced with concerns raised over behaviour of some participants

    Monday, 21 May 2018 17:00
  • NAPC issues guidance on community pharmacy role within primary care home programme

    NAPC issues guidance on community pharmacy role within primary care home programme

    Friday, 18 May 2018 14:13
  • Survey looks to improve ways pharmacy can share information

    Survey looks to improve ways pharmacy can share information

    Thursday, 17 May 2018 15:11

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a white pills imageFebruary 14 2018

GPs have increased long-term opioid prescribing for non-cancer pain against guidelines, an observational study has found. 

Analysis of prescription data for all opioids indicates the amounts prescribed has increased, and that there are regional variations. “More opioids were prescribed in the north than in the south of England, and more opioids were prescribed in areas of greater social deprivation,” the University of London researchers found. Nine out of ten of the highest prescribing areas were located in the north of the country.

Data from England was analysed for prescribing of eight opioids from August 2010 to February 2014. “Over the 43-month study, an overall increase in opioid prescribing was found, specifically of buprenorphine, codeine, morphine, oxycodone, and tramadol, which was the most prescribed opioid in England,” said the researchers.

The study suggests an increase in tramadol prescribing has resulted from the withdrawal of co-proxamol in the mid-2000s, but also as it is an alternative to non-steroidal inflammatory drug analgesia. It also notes: “Many practitioners routinely prescribe opioids for chronic non-cancer pain because they believe it is unethical to withhold analgesia, regardless of the aetiology of pain, yet opioids are ineffective in much chronic pain beyond modest effects in the short term.”

Responding to the study, Professor Helen Stokes-Lampard, Chair of the Royal College of General Practitioners, said: “While some prescribed medication has been shown to be addictive, many of these drugs, when used appropriately and in conjunction with established clinical guidelines, are safe to use and can, most importantly, help relieve patients from debilitating and painful symptoms.

“Patients are also made aware of any potential risks and side effects of taking any new medication – regardless of whether it is a known addictive drug or not – and consulted about if they think it is right for them. Additionally, all medication newly issued to a patient should have an information leaflet provided by the dispensing pharmacist.”

While the study has demonstrated an increase in opioid prescribing for non-cancer pain, she said that “most patients don’t want to be on long-term prescriptions and, where possible, GPs will always try to explore non-pharmacological treatments.” However, “these are often hard to come by at a community level, leaving family doctors with few alternatives that are still of equal benefit to the patient.”

Prof Stoke-Lampard called on GPs and their teams to encourage patients to attend regular medication reviews and urged doctors to ensure “these drugs are only prescribed for the shortest amount of time, which is tailored to the individual.”

Links:
L Mordecai et al. ‘Patterns of regional variation of opioid prescribing in primary care in England: a retrospective observational study’. Br J Gen Pract. Published 12 February 2018.       
RCGP comment           

Practice News

May 22 2018 A “bespoke, fully funded independent prescribing course for community pharmacists in NHS Scotland” has been announced by Community Pharmacy Scotland.
May 21 2018  NHS England and Capita’s handling of primary care support services has been criticised in an official report. The National Audit Office has published a review saying that “NHS England and...